Research Funding

Open opportunities and active NIH grants in structural heart and prosthetic valves

Open Opportunities

1 active
Federal9d left

NHLBI Stimulating Peripheral Activity to Relieve Conditions (SPARC)

National Heart, Lung, and Blood Institute (NIH)

NHLBI funding opportunities for cardiovascular device development including transcatheter and surgical valve technologies.

Varies
Deadline: Dec 1, 2026
US investigators
View opportunity

Funded Research

1 active grants · $428K total

Filter by Topic

Clear filters

Data from NIH Reporter. Updated weekly.

R01FY2026TricuspidRepair
$428K
Intracardiac beating heart tricuspid valve repair via robotics.
RANZANI, TOMMASO
ends Nov 30, 2028

Summary About 2.5% of the US population has a valvular heart disease. While neglected for a long time, problems related to the tricuspid valve affect more than 70 million people worldwide. Among these, more than 1.6 million are in the US. The yearly incidence is about 200,000 with a 1-year mortality rate of 36.1%. The most common problem is tricuspid valve regurgitation. The majority of tricuspid regurgitation cases are treated surgically via prosthetic ring annuloplasty in open surgery. However, open surgery approaches introduce risks of perioperative complications and require long recovery times. A large percentage of the population with tricuspid regurgitation cannot receive surgical treatment because of the high-risk profile. Few patients undergo isolated tricuspid valve surgery because the challenging anatomy of the tricuspid valve and lack of clinical experience has hindered progress in this area. Therefore, there is a clinical need for novel approaches that would allow tricuspid